Evidence map›Paper›PMID 35479529›Full record

ArticleRSC advances2021

Fabrication and characterisation of a silicon-borosilicate glass microfluidic device for synchrotron-based hard X-ray spectroscopy studies.

Pushparani Micheal Raj, Laurent Barbe, Martin Andersson, Milena De Albuquerque Moreira, Dörthe Haase, James Wootton, Susan Nehzati, Ann E Terry, Ross J Friel, Maria Tenje and 1 more

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pushparani Micheal RajMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.ORCID https://orcid.org/0000-0001-5235-3682
Laurent BarbeDept. Materials Science and Engineering, Science for Life Laboratory, Uppsala University Uppsala Sweden.
Martin AnderssonDept. Materials Science and Engineering, Science for Life Laboratory, Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0002-3966-0220
Milena De Albuquerque MoreiraDept. Materials Science and Engineering, Science for Life Laboratory, Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0002-7076-1580
Dörthe HaaseMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.
James WoottonMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.
Susan NehzatiMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.
Ann E TerryMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.
Ross J FrielSchool of Information Technology, Halmstad University Halmstad Sweden.ORCID https://orcid.org/0000-0002-0480-4079
Maria TenjeDept. Materials Science and Engineering, Science for Life Laboratory, Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0002-1264-1337
Kajsa G V Sigfridsson ClaussMAX IV Laboratory, Lund University Lund Sweden pushpa.micheal@gmail.com.ORCID https://orcid.org/0000-0002-7604-251X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some of the most fundamental chemical building blocks of life on Earth are the metal elements. X-ray absorption spectroscopy (XAS) is an element-specific technique that can analyse the local atomic and electronic structure of, for example, the active sites in catalysts and energy materials and allow the metal sites in biological samples to be identified and understood. A microfluidic device capable of withstanding the intense hard X-ray beams of a 4th generation synchrotron and harsh chemical sample conditions is presented in this work. The device is evaluated at the

Identifiers

PMID35479529
PMCPMC9040903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.